Two insiders at Outlook Therapeutics, Inc. (OTLK) have made significant share purchases totaling approximately $10.08 million. Ghiath M. Sukhtian acquired 8,539,709 shares for $5.04 million, while Ventures & Investments Gms also purchased 8,539,709 shares for $5.04 million.
These transactions, executed at a price of $0.59 per share, represent substantial investments by individuals closely associated with the company. Cluster buying, where multiple insiders purchase shares in close proximity, is often interpreted as a strong bullish signal by market observers.
The recent activity indicates a notable vote of confidence from these insiders in Outlook Therapeutics' future prospects.